The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA)
by
, ,
Naoki Motomura
1, 
Yuto Yamazaki
1,*,
Daiki Koga
1,
Shogo Harashima
1,
Xin Gao
1,
Yuta Tezuka
2,3,
Kei Omata
2,3,
Yoshikiyo Ono
2,3,
Ryo Morimoto
3,
Fumitoshi Satoh
2,3,
Yasuhiro Nakamura
4,
Go Eun Kwon
5,
Man Ho Choi
5,
Akihiro Ito
6 and
Hironobu Sasano
1 1
Department of Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
2
Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
3
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai 980-8574, Japan
4
Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan
5
Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul 02792, Korea
6
Department of Urology, Tohoku University School of Medicine, Sendai 980-8574, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(4), 2174; https://doi.org/10.3390/ijms23042174
Submission received: 31 December 2021
/
Revised: 9 February 2022
/
Accepted: 14 February 2022
/
Published: 16 February 2022
(This article belongs to the Special Issue Molecular Advances in Aldosterone and Aldosterone Related Disorders)
Abstract
:Cortisol-producing adenoma (CPA) is composed of clear and compact cells. Clear cells are lipid abundant, and compact ones lipid poor but associated with higher production of steroid hormones. PRKACA mutation (PRKACA mt) in CPA patients was reported to be associated with more pronounced clinical manifestation of Cushing’s syndrome. In this study, we examined the association of histological features and genotypes with cholesterol uptake receptors and synthetic enzymes in 40 CPA cases, and with the quantitative results obtained by gas chromatography-mass spectrometry (GC-MS) analysis in 33 cases to explore their biological and clinical significance. Both cholesterol uptake receptors and synthetic enzymes were more abundant in compact cells. GC-MS analysis demonstrated that the percentage of compact cells was inversely correlated with the concentrations of cholesterol and cholesterol esters, and positively with the activity of cholesterol biosynthesis from cholesterol esters. In addition, hormone-sensitive lipase (HSL), which catalyzes cholesterol biosynthesis from cholesterol esters, tended to be more abundant in compact cells of PRKACA mt CPAs. These results demonstrated that both cholesterol uptake and biosynthesis were more pronounced in compact cells in CPA. In addition, more pronounced HSL expression in compact cells of PRKACA mt CPA could contribute to their more pronounced clinical manifestation.
1. Introduction
Cortisol is synthesized from cholesterol through the cascades of steroidogenic enzymes including CYP17A1 and CYP11B1 in the zona fasciculata cells of human adrenal cortex. Intracellular free cholesterol is generally provided by three pathways: uptake of plasma cholesterols, metabolism of intracellularly stored cholesterol esters, and de novo biosynthesis [1]. Plasma cholesterol is the major source of cholesterol in steroidogenesis, and both low density lipoprotein receptor (LDL-R) and high density lipoprotein receptor, called scavenger receptor class B member 1 (SR-B1), are the main receptors responsible for plasma cholesterol uptake [1,2,3]. Of particular interest, SR-B1 is also known to mediate the selective uptake of cholesterol esters into the cells in steroidogenesis [3], and its deficiency was reported to result in decreased overall steroid production [4]. Hormone-sensitive lipase (HSL) is responsible for the biosynthesis of cholesterol from cholesterol esters, and both acyl-CoA:cholesterol acyltransferase 1 (ACAT1) and acyl-CoA:cholesterol acyltransferase 2 (ACAT2) catalyze the conversion of free cholesterol into cholesterol esters and also play important roles in maintaining the homeostasis of the intracellular cholesterol levels [1,5]. Several previously reported studies using HSL knockout mice revealed the significance of HSL in steroidogenesis [6,7,8]. In addition, results of in vitro studies using a human adrenocortical carcinoma cell line demonstrated that steroidogenic factor 1, which played a key role in enhancing expression of many essential steroidogenic enzymes, also activated HSL transcription [9,10]. 24-Dehydrocholesterol reductase (DHCR24) is also one of the key enzymes in the de novo cholesterol synthesizing pathway and catalyzes the cholesterol synthesis from acetyl-CoA [1].
Adrenal Cushing’s syndrome (CS) is characterized by autonomous cortisol over-secretion from the adrenal cortex. Cortisol-producing adenoma (CPA) is the most frequent subtype of ACTH-independent CS [11] and is histologically composed of two different cell subtypes: clear and compact tumor cells [12]. Clear cells have abundant lipid droplets, whereas compact cells are small-sized cells with few lipid droplets. We previously demonstrated that the steroidogenic enzyme expression status was higher in compact cells than in clear cells in CPA cases [12]. Both extracellular cholesterol uptake and de novo synthesis were recently reported to be higher in CPA than bilateral adrenal hyperplasia (BAH), indicating that CPA represented cholesterol starved status [13]. However, the association of cholesterol uptake and synthesis with histological features of CPA has remained virtually unknown.
Several previously reported studies revealed the presence of somatic gene mutations of PRKACA, GNAS, and CTNNB1 in CPA [14,15,16,17]. In particular, PRKACA mutation (PRKACA mt) was reported as the most frequently detected genetic alteration among Japanese CPA cases [12,18] and was associated with clinically more pronounced phenotypes of CS such as high plasma cortisol levels and overt CS [19,20,21]. In addition, PRKACA mt was reported to directly increase the steroidogenic enzyme expression by activating cAMP-PKA activity, and its gene expression profiles were different from CPAs harboring other mutations [22]. However, the association of cholesterol uptake and synthesis, both of which play pivotal roles in CPA, with the different genotypes above has also remained unexplored.
Therefore, in this study, we comprehensively analyzed the expression status of the receptors and enzymes responsible for cholesterol uptake and biosynthesis in CPAs. We also quantified the free cholesterol and its precursors and firstly examined their associations with tumor cell morphometry as well as genotypes in order to further explore the biological and clinical significance of cholesterol uptake and biosynthesis in CPAs.
2. Results
2.1. Comparison of Receptors and Enzymes between Clear Cells and Compact Cells
Hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) of receptors (LDL-R and SR-B1) and enzymes (ACAT1, ACAT2, HSL and DHCR24) were performed in CPAs (Figure 1). Results were semi-quantified and compared between clear and compact tumor cells (Table 1). Membranous immunoreactivity of SR-B1 (p = 0.0289), and cytoplasmic immunoreactivity of ACAT1 (p = 0.0004), ACAT2 (p < 0.0001), HSL (p < 0.0001) and DHCR24 (p < 0.0001) were significantly higher in compact than in clear tumor cells.
2.2. Correlations of Cholesterol Uptake and Biosynthesis with the Morphological Features
The correlation between the percentage of compact cells and concentrations of individual cholesterol and its precursors, their metabolic ratios and immunoreactivity of receptors and enzymes were examined (Table 2). Free cholesterol (ρ = −0.3789, p = 0.0299) and cholesterol arachidonate (Chol-A) (ρ = −0.3977, p = 0.0219) were both inversely correlated with the percentage of compact tumor cells (Table 2). All of the other cholesterol esters, cholesterol laurate (Chol-L) (ρ = −0.3252, p = 0.0648), cholesterol myristate (Chol-M) (ρ = −0.3289, p = 0.0617), cholesterol palmitate (Chol-P) (ρ = −0.3229, p = 0.0669) and cholesterol oleate, linoleate, and stearate (Chol-Li, O, S) (ρ = −0.3436, p = 0.0503) also tended to be inversely correlated with the proportion of compact cells, although the correlation did not reach statistical significance. On the other hand, there were no significant correlations between the concentrations of cholesterol precursors involved in de novo pathways and the percentage of compact cells.
The metabolic ratio of free cholesterol to Chol-A (cholesterol/Chol-A), representing the hydrolysis of cholesterol ester, was significantly positively correlated with the percentage of compact tumor cells in CPAs (ρ = 0.4047, p = 0.0195) (Table 2). All of the other metabolic ratios corresponding to cholesterol ester metabolism, cholesterol/Chol-L (ρ = 0.2978, p = 0.0923), cholesterol/Chol-M (ρ = 0.3282, p = 0.0622), cholesterol/Chol-P (ρ = 0.3145, p = 0.0747) and cholesterol/Chol-Li, O, S (ρ = 0.3436, p = 0.0503) also tended to be positively correlated with the percentage of compact cells. However, among the metabolic ratios corresponding to the de novo cholesterol synthesis activity, only cholesterol/7-dehydrocholesterol (7-DHC) tended to be inversely correlated with the percentage of compact tumor cells, but this did not reach statistical significance (ρ = 0.3275, p = 0.0628).
ACAT1 (ρ = 0.5893, p < 0.0001), ACAT2 (ρ = 0.3713, p = 0.0183) and DHCR24 (ρ = 0.4045, p = 0.0096) were all significantly positively correlated with the percentage of compact cells (Table 2). Membranous SR-B1 immunoreactivity tended to be inversely correlated with the percentage of compact cells, although the correlation did not reach statistical significance (ρ = 0.2674, p = 0.0953).
2.3. Differences in Cholesterol Uptake and Biosynthesis between PRKACA mt and Non-PRKACA mt
Differences in tissue concentrations of steroids, metabolic ratios and immunoreactivity of receptors and enzymes were compared between PRKACA mt and non-PRKACA mt CPA cases (Table 3).
No significant differences in concentrations of steroids examined and metabolic ratios were detected between PRKACA mt and non-mt cases. Only HSL immunoreactivity in compact tumor cells tended to be higher in PRKACA mt (p = 0.0859), although the correlation did not reach statistical significance.
3. Discussion
This is the first study to examine the association of cholesterol uptake and synthesis with morphology and genotypes in CPA.
Extracellular cholesterol uptake through LDL-R and SR-B1, and intracellular biosynthesis of free cholesterol by de novo synthesis and cholesterol ester metabolism are well-known sources of free cholesterol [1]. In addition, London E et al. also recently reported that extracellular cholesterol uptake via LDL-R and intracellular cholesterol synthesis through de novo pathways were both increased, and cholesterol efflux was decreased in CPA compared to BAH, which indicated that CPA could correspond to “cholesterol-starved tissues” [13]. On the other hand, the association of cholesterol uptake and synthesis with morphology and genotypes in CPA has remained virtually unknown.
In this study, we comprehensively semi-quantified the immunoreactivity of the receptors and enzymes involved in cholesterol uptake or biosynthesis in CPA. SR-B1, HSL and DHCR24 were all significantly higher in compact than clear tumor cells (Table 1). DHCR24 was also significantly positively correlated with the percentage of compact tumor cells (Table 2). In addition, the percentage of compact tumor cells was inversely correlated with the tissue concentrations of free cholesterol and cholesterol esters, and also positively with the activities of the cholesterol biosynthesis through the cholesterol ester metabolism (Table 2). These results all indicated that both plasma cholesterol uptake and intracellular cholesterol biosynthesis including the cholesterol synthesis from the cholesterol ester were activated in compact tumor cells (Figure 2A,B). In addition, lipid droplets in adrenocortical cells were reported to be mainly composed of cholesterol ester [23]. Therefore, the enhanced cholesterol ester metabolism in compact tumor cells detected in our present study was considered to decrease the volume of lipid droplets, subsequently resulting in the relative shrinkage of the cytoplasm compared to clear cells. This could also contribute to the characteristic morphological features of compact tumor cells, i.e., small size with few lipid droplets, and demonstrated that these cells corresponded to cholesterol starved cells. However, further investigations are warranted to clarify the roles of cholesterol ester metabolism in the process of development of these characteristic histological features of tumor cells in CPA.
In addition, we previously reported the associations of steroid hormone synthesis with histology and cellular senescence in CPA [12]. In our previous study, hormonal activity was significantly higher and cell senescence more progressed in compact tumor cells, which suggested that the cell senescence in compact tumor cells was caused by in situ excessive cortisol exposure in local tissue microenvironment [12,24]. In this study, we demonstrated that the supply of free cholesterol was elevated in compact tumor cells (Table 1), which is consistent with the previously reported higher hormonal activity in compact tumor cells and supported the hypothesis that the cell senescence was more pronounced in compact tumor cells by excessive cortisol exposure.
In addition, ACAT1 and ACAT2 were both significantly higher in compact than clear tumor cells (Table 1 and Table 2), suggesting that they were in equilibrium with cholesterol ester metabolism to maintain the homeostasis of intracellular free cholesterol levels [5]. As for the de novo pathway, DHCR24 was higher in compact tumor cells (Table 1) but there were no significant correlations detected between the morphological parameter (the percentage of compact cells) and de novo pathway activities (Table 2). This could indicate the fact that both the enzymes and the sufficient quantity of substrates were required for the metabolism to proceed, and the expression of the synthase did not necessarily directly reflect the progression of metabolism. A previously reported study also demonstrated that the localization of the synthase did not necessarily correspond to that of the metabolites and their precursor [25]. In our present study, the concentrations of steroids involved in the de novo pathway were not necessarily correlated with the percentage of compact tumor cells (Table 2). This could have caused the discrepancy between DHCR24 expression and de novo pathway activity, but it is also important to note that we could not separately analyze the clear and compact tumor cells in our present study using GC-MS. Therefore, further investigations are required to clarify the correlation between histological features and de novo pathway activity, including differences in steroid contents between clear and compact tumor cells of CPA. In addition, the cytoplasmic immunoreactivity of LDL-R and SR-B1 was detected in this study, and we therefore examined the correlations between LDL-R/SR-B1 in the cytoplasm and membrane, respectively (Supplemental Figure S1). Both of them were significantly positively correlated, suggesting the equilibrium between those two above, and cytoplasmic immunoreactivity could represent the cholesterol uptake into the cell.
In our present study, we also examined the correlation between genetic mutations and cholesterol uptake and synthesis. Results demonstrated that HSL in compact tumor cells tended to be higher in the CPA cases harboring PRKACA mt than non-PRKACA mt cases (Table 3). PRKACA mt was reported to increase the expression of steroid hormone synthases [22], and to represent clinically more pronounced phenotypes of CS [19,20,21]. Therefore, the expression of HSL could have been increased following the increased expression of steroidogenic enzymes and demands for the free cholesterol by PRKACA mt, and could contribute to more severe phenotypes, e.g., higher serum cortisol levels.
4. Materials and Methods
4.1. Human Adrenals
A total of 40 cases of CPAs (PRKACA mt: n = 20, non-PRKACA mt: n = 20) operated at Tohoku University Hospital, Sendai, Japan from 2015 to 2018 were examined in this study. All of the cases were clinically diagnosed as adrenal CS [26]. Based on the genetic mutations of each case, we retrieved 40 CPAs so that the number of cases of PRKACA mt and non-PRKACA mt would be equal [12]. The clinical features of 40 cases were summarized in Table 1. For histopathological analysis, 40 cases of 10% formalin fixed paraffin embedded (FFPE) tissues were used. Among these 40 cases, 33 cases (PRKACA mt: n = 16, non-PRKACA mt: n = 17) were available as optimal cutting temperature-embedded frozen tissues, and GC-MS analysis was performed in all of these cases.
4.2. H&E Staining and IHC
H&E staining and IHC of free cholesterol uptake receptors (LDL-R and SR-B1) and metabolic enzymes (ACAT1, ACAT2, HSL and DHCR24) were performed in FFPE specimens. FFPE tissues were sliced at 3 µm thickness using a microtome (Yamato Kohki Industrial Co., Ltd., Saitama, Japan). IHC protocols were summarized in Supplemental Table S1.
4.3. Semi-Quantitative Evaluation of Morphology and Immunoreactivity
All stained tissue sections were digitally scanned by Image Scope AT2 (Leica, Wetzler, Germany). H&E staining was evaluated by HALO TM Area Quantification ver.1.0 (Indica Labs, Corrales, NM, USA) program as previously reported [27]. Tumor cells were tentatively classified into the nucleus and cytoplasm, and they were further classified into compact and clear tumor cells. The percentage of compact cells partly obtained from the historical data [12] were used as the morphological parameters. Cytoplasmic immunoreactivity of all the enzymes examined in this study was evaluated by using HALO TM CytoNuclear ver.1.5 (Indica Labs) program, and semi-quantified [12,27,28,29,30]. Positive cells were tentatively classified into +1 (Weak), +2 (Moderate) and +3 (Strong) according to their immunointensity. The H-Score was subsequently calculated according to the following formula: Σ (Number of individual immunopositive cells × Immunointensity score (+1, +2, +3)/Number of total cells) X 100. Cytoplasmic immunoreactivity of LDL-R and SR-B1 was also semi-quantified according to the same formula, and the correlation with the immunoreactivity in the membrane was examined (Supplemental Figure S1). Immunoreactivity of LDL-R and SR-B1 in the membrane was evaluated by HALO TM Membrane Quantification ver. 1.7 (Indica Labs). PIC-Score was defined and used for the semi-quantification. PIC-Score was calculated according to the following formula: PIC-Score = Percentage of positive cells (Percentage) × Average positive cell membrane optical density (Intensity) × Average positive membrane completeness (Circumference).
4.4. Quantitative Metabolic Signatures of Cholesterols Using GC-MS
Free cholesterol, 7 cholesterol esters (Chol-L, Chol-M, Chol-A, Chol-P, Chol-Li, O, S) and 4 cholesterol precursors involved in de novo pathways (desmosterol; Des, 7-DHC, lathosterol; Latho, lanosterol; Lano) were quantitatively analyzed as previously reported [31,32].
Each cholesterol ester metabolism and de novo synthesis activity was analyzed by the corresponding metabolic ratios [33]. The metabolic ratio was calculated according to the following formula: metabolic ratio = the concentration of cholesterol/the concentration of corresponding precursors. Cholesterol/cholesterol esters (Chol-L, Chol-M, Chol-A, Chol-P and Chol-Li, O, S) were used as an index of the cholesterol ester metabolism activity, and cholesterol/cholesterol precursors involved in de novo pathways (Des, 7-DHC, Latho, Lano) were used for the index of de novo synthesis activity.
4.5. Statistical Analysis
All the results were statistically analyzed by the software “JMP Pro 16.0”. The correlation between the percentage of compact cells and immunoreactivities of receptors and enzymes, steroids’ concentrations and metabolic ratios were analyzed by the Spearman’s rank correlation coefficient test. The difference in the immunoreactivities of receptors and enzymes between clear cells and compact cells, and the difference in the immunoreactivities of receptors and enzymes, steroids’ concentration, metabolic ratios between PRKACA mt and non-PRKACA mt were analyzed by Mann–Whitney’s U test. In all statistical analyses, the significance was regarded as p-value < 0.05.
5. Conclusions
We firstly revealed the association of cholesterol uptake and biosynthesis with the morphology and genotypes of CPA using both semi-quantitative histopathological analysis and GC-MS analysis. In clear tumor cells, in which steroidogenic enzymes were reported low and lipid was abundantly stored, both extracellular cholesterol uptake and intracellular cholesterol biosynthesis were relatively low. On the other hand, in compact tumor cells, where steroidogenic enzymes were relatively abundant and lipid poor, both extracellular cholesterol uptake and intracellular cholesterol biosynthesis were elevated. In particular, the increased activity of the cholesterol biosynthesis from cholesterol esters was demonstrated, which could contribute to the high hormonal activity and the formation of morphological characteristics of compact tumor cells. In addition, HSL in compact tumor cells was more abundant in CPA cases harboring PRKACA mt than non mt cases, which could contribute to the development of clinically more severe phenotypes such as higher serum cortisol levels and overt CS.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms23042174/s1.
Author Contributions
Conceptualization, N.M., Y.Y., D.K., S.H., F.S., M.H.C., H.S.; Methodology, N.M., Y.Y., D.K., S.H., G.E.K., M.H.C., H.S.; Formal Analysis, N.M., Y.Y.; Investigation, N.M., D.K., X.G., G.E.K.; Resources, Y.T., K.O., Y.O., R.M., F.S., G.E.K., M.H.C., A.I.; Data Curation, N.M.; Writing—Original Draft Preparation, N.M.; Writing—Review & Editing, Y.Y., D.K., S.H., X.G., Y.T., K.O., Y.O., R.M., F.S., Y.N., G.E.K., M.H.C., A.I., H.S.; Visualization, N.M., Y.Y.; Supervision, Y.Y.; Project Administration, Y.Y., H.S.; Funding Acquisition, H.S. All authors have read and agreed to the published version of the manuscript.
Funding
This study was funded by grants from the Ministry of Health, Labour, and Welfare, Japan (No. 20FC1020).
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Tohoku University School of Medicine (2020-1-477).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study. For the use of the specimens and the clinical information of the patients in this present study, the “opt-out format” was adapted because the design of the study was retrospective. The research protocol was published on the website of Tohoku University Graduate School of Medicine.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Acknowledgments
We thank Celso E. Gomez-Sanchez for providing CYP11B2 IHC antibody. We also thank Biomedical Research Unit of Tohoku University Hospital for technical support of sanger sequence.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Miller, W.L.; Bose, H.S. Early steps in steroidogenesis: Intracellular cholesterol trafficking. J. Lipid. Res. 2011, 52, 2111–2135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, J.; Heikkilä, P.; Meng, Q.-H.; Kahri, A.I.; Tikkanen, M.J.; Voutilainen, R. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur. J. Endocrinol. 2000, 142, 677–682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Azhar, S.; Reaven, E. Scavenger receptor class BI and selective cholesteryl ester uptake: Partners in the regulation of steroidogenesis. Mol. Cell Endocrinol. 2002, 195, 1–26. [Google Scholar] [CrossRef]
- Vergeer, M.; Korporaal, S.J.A.; Franssen, R.; Meurs, I.; Out, R.; Kees Hovingh, G.; Hoekstra, M.; Sierts, J.A.; Dallinga-Thie, G.M.; Motazacker, M.M.; et al. Genetic variant of the scavenger receptor BI in humans. N. Engl. J. Med. 2011, 364, 136–145. [Google Scholar] [CrossRef] [PubMed]
- Tosi, M.R.; Tugnoli, V. Cholesteryl esters in malignancy. Clin. Chim. Acta 2005, 359, 27–45. [Google Scholar] [CrossRef]
- Kraemer, F.; Shen, W.; Natu, V.; Patel, S.; Osuga, J.; Ishibashi, S.; Azhar, S. Adrenal neutral cholesteryl ester hydrolase: Identification, subcellular distribution, and sex differences. Endocrinology 2002, 143, 801–806. [Google Scholar] [CrossRef]
- Hong, L.; Brochu, M.; Pei Wang, S.; Rochdi, L.; Côté, M.; Mitchell, G.; Gallo-Payet, N. Hormone-sensitive lipase deficiency in mice causes lipid storage in the adrenal cortex and impaired corticosterone response to corticotropin stimulation. Endocrinology 2002, 143, 3333–3340. [Google Scholar] [CrossRef] [Green Version]
- Kraemer, F.B.; Shen, W.J.; Harada, K.; Patel, S.; Osuga, J.I.; Ishibashi, S.; Azhar, S. Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis. Mol. Endocrinol. 2004, 18, 549–557. [Google Scholar] [CrossRef] [Green Version]
- Hołysz, M.; Derebecka-Hołysz, N.; Trzeciak, W.H. Transcription of LIPE gene encoding hormone-sensitive lipase/cholesteryl esterase is regulated by SF-1 in human adrenocortical cells: Involvement of protein kinase A signal transduction pathway. J. Mol. Endocrinol. 2011, 46, 29–36. [Google Scholar] [CrossRef] [Green Version]
- Val, P.; Lefrançois-Martinez, A.-M.; Veyssière, G.; Martinez, A. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 2003, 1, 8. [Google Scholar] [CrossRef] [Green Version]
- Lam, A.K.-Y. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr. Pathol. 2017, 28, 213–227. [Google Scholar] [CrossRef] [PubMed]
- Gao, X.; Yamazaki, Y.; Tezuka, Y.; Pieroni, J.; Ishii, K.; Atsumi, N.; Ono, Y.; Omata, K.; Morimoto, R.; Nakamura, Y.; et al. Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; ∼An association among morphometry, genotype and cellular senescence∼. J. Steroid. Biochem. Mol. Biol. 2020, 204, 105764. [Google Scholar] [CrossRef]
- London, E.; Wassif, C.A.; Horvath, A.; Tatsi, C.; Angelousi, A.; Karageorgiadis, A.S.; Porter, F.D.; Stratakis, C.A. Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex. J. Clin. Endocrinol. Metab. 2015, 100, 3660–3667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cao, Y.; He, M.; Gao, Z.; Peng, Y.; Li, Y.; Li, L.; Zhou, W.; Li, X.; Zhong, X.; Lei, Y.; et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome. Science 2014, 344, 913–917. [Google Scholar] [CrossRef] [PubMed]
- Beuschlein, F.; Fassnacht, M.; Assié, G.; Calebiro, D.; Stratakis, C.A.; Osswald, A.; Ronchi, C.L.; Wieland, T.; Sbiera, S.; Faucz, F.R.; et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N. Engl. J. Med. 2014, 370, 1019–1028. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Calebiro, D.; Hannawacker, A.; Lyga, S.; Bathon, K.; Zabel, U.; Ronchi, C.; Beuschlein, F.; Reincke, M.; Lorenz, K.; Allolio, B.; et al. PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit. Nat. Commun. 2014, 5, 5680. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goh, G.; Scholl, U.I.; Healy, J.M.; Choi, M.; Prasad, M.L.; Nelson-Williams, C.; Kuntsman, J.W.; Korah, R.; Suttorp, A.C.; Dietrich, D.; et al. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet. 2014, 46, 613–617. [Google Scholar] [CrossRef] [Green Version]
- Nakajima, Y.; Okamura, T.; Gohko, T.; Satoh, T.; Hashimoto, K.; Shibusawa, N.; Ozawa, A.; Ishii, S.; Tomaru, T.; Horiguchi, K.; et al. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr. J. 2014, 61, 825–832. [Google Scholar] [CrossRef] [Green Version]
- Li, X.; Wang, B.; Tang, L.; Lang, B.; Zhang, Y.; Zhang, F.; Chen, L.; Ouyang, J.; Zhang, X. Clinical Characteristics of PRKACA Mutations in Chinese Patients with Adrenal Lesions: A Single-Centre Study. Clin. Endocrinol. 2016, 85, 954–961. [Google Scholar] [CrossRef]
- di Dalmazi, G.; Kisker, C.; Calebiro, D.; Mannelli, M.; Canu, L.; Arnaldi, G.; Quinkler, M.; Rayes, N.; Tabarin, A.; Jullié, M.L.; et al. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing’s syndrome: A European multicentric study. J. Clin. Endocrinol. Metab. 2014, 99, E2093–E2100. [Google Scholar] [CrossRef]
- Thiel, A.; Reis, A.C.; Haase, M.; Goh, G.; Schott, M.; Willenberg, H.S.; Scholl, U.I. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: A single-center study of 60 cases. Eur. J. Endocrinol. 2015, 172, 677–685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baba, R.; Oki, K.; Gomez-Sanchez, C.E.; Otagaki, Y.; Itcho, K.; Kobuke, K.; Kodama, T.; Nagano, G.; Ohno, H.; Yoneda, M.; et al. Genotype-specific cortisol production associated with Cushing’s syndrome adenoma with PRKACA mutations. Mol. Cell Endocrinol. 2021, 538, 111456. [Google Scholar] [CrossRef] [PubMed]
- Shen, W.J.; Azhar, S.; Kraemer, F.B. Lipid droplets and steroidogenic cells. Exp. Cell Res. 2016, 340, 209–214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kitawaki, Y.; Nakamura, Y.; Kubota-Nakayama, F.; Yamazaki, Y.; Miki, Y.; Hata, S.; Ise, K.; Kikuchi, K.; Morimoto, R.; Satoh, F.; et al. Tumor microenvironment in functional adrenocortical adenomas: Immune cell infiltration in cortisol-producing adrenocortical adenoma. Hum. Pathol. 2018, 77, 88–97. [Google Scholar] [CrossRef] [PubMed]
- Duncan, K.D.; Sun, X.; Baker, E.S.; Dey, S.K.; Lanekoff, I. In situ imaging reveals disparity between prostaglandin localization and abundance of prostaglandin synthases. Commun. Biol. 2021, 4, 1010. [Google Scholar] [CrossRef]
- Nieman, L.K.; Biller, B.M.K.; Findling, J.W.; Newell-Price, J.; Savage, M.O.; Stewart, P.M.; Montori, V.M.; Edwards, H. The diagnosis of Cushing’s syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008, 93, 1526–1540. [Google Scholar] [CrossRef] [PubMed]
- Yamazaki, Y.; Omata, K.; Tezuka, Y.; Ono, Y.; Morimoto, R.; Adachi, Y.; Ise, K.; Nakamura, Y.; Gomez-Sanchez, C.E.; Shibahara, Y.; et al. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma. Hypertension 2018, 72, 632–640. [Google Scholar] [CrossRef]
- Yamazaki, Y.; Nakamura, Y.; Omata, K.; Ise, K.; Tezuka, Y.; Ono, Y.; Morimoto, R.; Nozawa, Y.; Gomez-Sanchez, C.E.; Tomlins, S.A.; et al. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism. J. Clin. Endocrinol. Metab. 2017, 102, 1182–1192. [Google Scholar] [CrossRef]
- Konosu-Fukaya, S.; Nakamura, Y.; Satoh, F.; Felizola, S.J.A.; Maekawa, T.; Ono, Y.; Morimoto, R.; Ise, K.; Takeda, K.I.; Katsu, K.; et al. 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. Mol. Cell Endocrinol. 2015, 408, 205–212. [Google Scholar] [CrossRef] [Green Version]
- Budwit-Novotny, D.A.; Mccarty, K.S.; Cox, E.B.; Soper, J.T.; Mutch, D.G.; Creasman, W.T.; Flowers, J.L.; McCarty, K.S., Jr. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986, 46, 5419–5425. [Google Scholar]
- Son, H.H.; Moon, J.Y.; Seo, H.S.; Kim, H.H.; Chung, B.C.; Choi, M.H. High-temperature GC-MS-based serum cholesterol signatures may reveal sex differences in vasospastic angina. J. Lipid. Res. 2014, 55, 155–162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moon, J.Y.; McNamara, K.M.; Lee, J.J.; Chung, B.C.; Sasano, H.; Choi, M.H. Improved detectability of sex steroids from frozen sections of breast cancer tissue using GC-triple quadrupole-MS. J. Steroid. Biochem. Mol. Biol. 2018, 178, 185–192. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.H.; Moon, J.Y.; Sasano, H.; Choi, M.H.; Park, M.J. Body Fat Mass Is Associated With Ratio of Steroid Metabolites Reflecting 17,20-Lyase Activity in Prepubertal Girls. J. Clin. Endocrinol. Metab. 2016, 101, 4653–4660. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1.
Representative image of H&E staining and IHC. H&E staining and IHC of LDL-R, SR-B1, ACAT1, ACAT2, HSL and DHCR24.
Figure 1.
Representative image of H&E staining and IHC. H&E staining and IHC of LDL-R, SR-B1, ACAT1, ACAT2, HSL and DHCR24.
Figure 2.
Difference in cholesterol uptake and synthesis depending on morphological features. Differences in cholesterol uptake and metabolism depending on the status of each cell in CPA are illustrated. (A): Cholesterol uptake and biosynthesis in relatively cholesterol enriched cells including clear tumor cells. Both cholesterol uptake and synthesis were low, and hormonal activity was also relatively low. (B): Cholesterol uptake and synthesis in cholesterol starved cells including compact tumor cells. Both cholesterol uptake and synthesis were increased, and hormonal activity was high. Increased cholesterol synthesis through the cholesterol ester metabolism could contribute to its characteristic shrinked morphology.
Figure 2.
Difference in cholesterol uptake and synthesis depending on morphological features. Differences in cholesterol uptake and metabolism depending on the status of each cell in CPA are illustrated. (A): Cholesterol uptake and biosynthesis in relatively cholesterol enriched cells including clear tumor cells. Both cholesterol uptake and synthesis were low, and hormonal activity was also relatively low. (B): Cholesterol uptake and synthesis in cholesterol starved cells including compact tumor cells. Both cholesterol uptake and synthesis were increased, and hormonal activity was high. Increased cholesterol synthesis through the cholesterol ester metabolism could contribute to its characteristic shrinked morphology.
Table 1.
Comparison of immunoreactivities of receptors and enzymes between clear cells and compact cells. Immunoreactivity of LDL-R, SR-B1, ACAT1, ACAT2, HSL and DHCR24 in both clear and compact tumor cells was semi-quantified and evaluated. Except for LDL-R, immunoreactivity of all the receptor and enzymes examined in this study were higher in compact than in clear tumor cells. The values of each factor were represented by the median [Range: 1st quartile, 3rd quartile].
Table 1.
Comparison of immunoreactivities of receptors and enzymes between clear cells and compact cells. Immunoreactivity of LDL-R, SR-B1, ACAT1, ACAT2, HSL and DHCR24 in both clear and compact tumor cells was semi-quantified and evaluated. Except for LDL-R, immunoreactivity of all the receptor and enzymes examined in this study were higher in compact than in clear tumor cells. The values of each factor were represented by the median [Range: 1st quartile, 3rd quartile].
| Cholesterol Uptake/Synthesis | Clear Cell | Compact Cell | p-Value |
|---|---|---|---|
| LDL-R PIC-Score | 301.064 [171.6032–409.4358] | 358.1922 [208.0366–472.4762] | p = 0.2235 |
| SR-B1 PIC-Score | 8.0921 [0.0049–101.5824] | 80.7402 [2.1292–511.6923] | p = 0.0289 |
| ACAT1 H-Score | 14.1902 [2.0041–41.7950] | 66.8817 [15.3391–126.5957] | p = 0.0004 |
| ACAT2 H-Score | 68.7927 [23.7838–93.2270] | 196.1126 [151.3714–234.4872] | p < 0.0001 |
| HSL H-Score | 32.4039 [7.5268–71.3349] | 139.3665 [84.8874–194.0853] | p < 0.0001 |
| DHCR24 H-Score | 69.3694 [30.7692–95.6722] | 131.619 [99.8727–150.6372] | p < 0.0001 |
Table 2.
Correlations between the percentage of compact cells and the cholesterol uptake/synthesis. The correlation between the percentage of compact cells and concentrations of individual cholesterol and its precursors, their metabolic ratios and immunoreactivity of receptors and enzymes were examined. Free cholesterol and cholesterol ester (Chol-L, Chol-M, Chol-P, Chol-A, Chol-Li, O, S) concentrations were significantly or tended to be inversely correlated with the percentage of the compact cells. The metabolic ratios corresponding to the activity of cholesterol ester metabolism (cholesterol/Chol-L, cholesterol/Chol-M, cholesterol/Chol-P, cholesterol/Chol-P, cholesterol/Chol-Li, O, S) were significantly or tended to be positively correlated with the percentage of compact cells, and cholesterol/7-DHC tended to be inversely correlated. ACAT1, ACAT2 and DHCR24 were positively correlated with the percentage of compact tumor cells, but SR-B1 tended to be inversely correlated.
Table 2.
Correlations between the percentage of compact cells and the cholesterol uptake/synthesis. The correlation between the percentage of compact cells and concentrations of individual cholesterol and its precursors, their metabolic ratios and immunoreactivity of receptors and enzymes were examined. Free cholesterol and cholesterol ester (Chol-L, Chol-M, Chol-P, Chol-A, Chol-Li, O, S) concentrations were significantly or tended to be inversely correlated with the percentage of the compact cells. The metabolic ratios corresponding to the activity of cholesterol ester metabolism (cholesterol/Chol-L, cholesterol/Chol-M, cholesterol/Chol-P, cholesterol/Chol-P, cholesterol/Chol-Li, O, S) were significantly or tended to be positively correlated with the percentage of compact cells, and cholesterol/7-DHC tended to be inversely correlated. ACAT1, ACAT2 and DHCR24 were positively correlated with the percentage of compact tumor cells, but SR-B1 tended to be inversely correlated.
| Steroids’ Concentration/ Metabolic Ratio /Cholesterol Uptake or Synthesis | Compact Cell (%) |
|---|---|
| Cholesterol | ρ = −0.3783, p = 0.0299 |
| Chol-L | ρ = −0.3252, p = 0.0648 |
| Chol-M | ρ = −0.3289, p = 0.0617 |
| Chol-P | ρ = −0.3229, p = 0.0669 |
| Chol-Li, O, S | ρ = −0.3436, p = 0.0503 |
| Chol-A | ρ = −0.3977, p = 0.0219 |
| Des | ρ = −0.0267, p = 0.8826 |
| 7-DHC | ρ = 0.1541, p = 0.3919 |
| Latho | ρ = 0.1501, p = 0.4045 |
| Lano | ρ = 0.2136, p = 0.2327 |
| Cholesterol/Chol-L | ρ = 0.2978, p = 0.0923 |
| Cholesterol/Chol-M | ρ = 0.3282, p = 0.0622 |
| Cholesterol/Chol-P | ρ = 0.3145, p = 0.0747 |
| Cholesterol/Chol-Li, O, S | ρ = 0.3436, p = 0.0503 |
| Cholesterol/Chol-A | ρ = 0.4047, p = 0.0195 |
| Cholesterol/Des | ρ = −0.2025, p = 0.2583 |
| Cholesterol/7-DHC | ρ = −0.3275, p = 0.0628 |
| Cholesterol/Latho | ρ = −0.2340, p = 0.1900 |
| Cholesterol/Lano | ρ = −0.2774, p = 0.1181 |
| LDL-R PIC-Score | ρ = −0.1450, p = 0.3719 |
| SR-B1 PIC-Score | ρ = −0.2674, p = 0.0953 |
| ACAT1 H-Score | ρ = 0.5893, p < 0.0001 |
| ACAT2 H-Score | ρ = 0.3713, p = 0.0183 |
| HSL H-Score | ρ = 0.0181, p = 0.9117 |
| DHCR24 H-Score | ρ = 0.4045, p = 0.0096 |
Abbreviation; Chol-L (cholesterol laurate), Chol-M (cholesterol myristate), Chol-P, (cholesterol palmitate), Chol-Li, O, S, (cholesterol oleate, linoleate, stearate), Chol-A (cholesterol arachidonate), Des (desmosterol), 7-DHC (7-dehydrocholesterol), Latho (lathosterol), Lano (lanosterol).
Table 3.
Differences in cholesterol uptake/synthesis between PRKACA mt and non-PRKACA mt. HSL in compact cells tended to be higher in PRKACA mt cases but the difference did not reach statistical significance. The values of each factor were represented by the median [Range: 1st quartile, 3rd quartile].
Table 3.
Differences in cholesterol uptake/synthesis between PRKACA mt and non-PRKACA mt. HSL in compact cells tended to be higher in PRKACA mt cases but the difference did not reach statistical significance. The values of each factor were represented by the median [Range: 1st quartile, 3rd quartile].
| Steroids’ Concentration/ Metabolic Ratio/ Cholesterol Uptake or Synthesis | PRKACA mt | Non-PRKACA mt | p-Value |
|---|---|---|---|
| Cholesterol | 5861.593 [5382.19–7136.4] | 5898.944 [4665.091–7147.887] | p = 0.7870 |
| Chol-L | 46.3632 [29.3517–147.358] | 64.4895 [9.1374–180.7776] | p = 0.8712 |
| Chol-M | 7589.288 [4313.768–20519.77] | 10,336.66 [463.5112–25,550.09] | p = 0.7322 |
| Chol-P | 12,178.57 [6960.808–33,207.79] | 14,221.98 [2074.188–28,670.039] | p = 0.8430 |
| Chol-Li, O, S | 52,515.09 [24,018.31–133,299.5] | 60,127.17 [6245.443–13,0951.9] | p = 0.8712 |
| Chol-A | 158,586.2 [67,639.35–479,610.3] | 169,709.2 [12,355.74–283,133.6] | p = 0.6525 |
| Des | 0.3454 [0.2962–0.3835] | 0.3152 [0.2789–0.4438] | p = 0.8997 |
| 7-DHC | 0.4979 [0.4369–0.5973] | 0.4975 [0.4432–0.6815] | p = 0.5284 |
| Latho | 2.2336 [1.4522–3.7237] | 3.0636 [1.0444–5.4423] | p = 0.8712 |
| Lano | 0.4145 [0.2240–1.2060] | 0.4596 [0.2714–1.2257] | p = 0.6268 |
| Cholesterol/Chol-L | 124.5981 [52.8000–187.3307] | 92.5434 [42.4202–409.0853] | p = 0.8430 |
| Cholesterol/Chol-M | 0.7128 [0.3678–1.2558] | 0.5590 [0.2862–9.5894] | p = 0.6787 |
| Cholesterol/Chol-P | 0.4522 [0.2144–0.7773] | 0.4714 [0.2330–2.1314] | p = 0.7595 |
| Cholesterol/Chol-Li, O, S | 0.1026 [0.0583–0.2294] | 0.1127 [0.0529–0.7270] | p = 0.7870 |
| Cholesterol/Chol-A | 0.0342 [0.0163–0.0802] | 0.0374 [0.0246–0.3992] | p = 0.5052 |
| Cholesterol/Des | 19,352.06 [13,583.11–21,680.68] | 17,301.79 [13,320.42–20,975.02] | p = 0.7322 |
| Cholesterol/7-DHC | 12,867.24 [8889.587–15,722.16] | 11,032.05 [7518.443–14,785.94] | p = 0.3775 |
| Cholesterol/Latho | 3216.884 [1521.676–4723.64] | 1764.608 [1048.45–6886.364] | p = 0.7870 |
| Cholesterol/Lano | 17,697.64 [4566.075–28014.47] | 14,490.77 [4024.852–24,823.25] | p = 0.5284 |
| LDL-R PIC-Score of whole tumor area | 255.5031 [204.7156–341.0808] | 212.0748 [135.9559–311.1807] | p = 0.1556 |
| SR-B1 PIC-Score of whole tumor area | 26.7668 [2.4042–131.9024] | 8.4648 [0.1653–54.8108] | p = 0.1850 |
| ACAT1 H-Score of whole tumor area | 35.5899 [6.2073–79.4407] | 50.0042 [12.6475–79.9881] | p = 0.6949 |
| ACAT2 H-Score of whole tumor area | 125.6836 [114.6927–143.0224] | 133.8384 [108.0684–145.4952] | p = 0.7150 |
| HSL H-Score of whole tumor area | 83.0157 [65.9521–109.9652] | 61.2836 [22.7286–93.5136] | p = 0.1135 |
| DHCR24 H-Score of whole tumor area | 118.1096 [109.633–127.5966] | 114.9842 [105.6652–124.4034] | p = 0.4570 |
| LDL-R PIC-Score of clear cells | 261.9615 [177.38–406.2435] | 374.8266 [55.4230–417.4899] | p = 0.4072 |
| SR-B1 PIC-Score of clear cells | 26.4515 [0.1785–68.7130] | 0.6045 [2.979 × 10-5–145.6982] | p = 0.4149 |
| ACAT1 H-Score of clear cells | 8.2791 [1.5629–36.5925] | 20.8763 [2.0101–54.7858] | p = 0.4396 |
| ACAT2 H-Score of clear cells | 68.4305 [27.0601–85.8050] | 72.2039 [18.6502–99.2369] | p = 0.8331 |
| HSL H-Score of clear cells | 37.2177 [9.7030–76.4627] | 15.2488 [2.2614–68.1975] | p = 0.3466 |
| DHCR24 H-Score of clear cells | 64.9594 [29.4409–96.4883] | 60.7895 [19.7590–95.6722] | p = 0.5273 |
| LDL-R PIC-Score of compact cells | 273.4003 [146.7106–432.0079] | 370.1031 [251.1391–552.4103] | p = 0.2503 |
| SR-B1 PIC-Score of compact cells | 144.6817 [4.0369–456.7502] | 15.6289 [0.3782–301.3014] | p = 0.1805 |
| ACAT1 H-Score of compact cells | 47.5116 [7.4780–118.3264] | 84.5003 [20.8420–140.7282] | p = 0.2792 |
| ACAT2 H-Score of compact cells | 198.1139 [168.0626–233.9138] | 194.5094 [138.6214–237.463] | p = 0.5428 |
| HSL H-Score of compact cells | 153.2234 [103.4131–199.9192] | 110.781 [66.3701–166.0313] | p = 0.0859 |
| DHCR24 H-Score of compact cells | 131.619 [98.1391–149.6554] | 125.5617 [99.8727–155.1823] | p = 0.8817 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Motomura, N.; Yamazaki, Y.; Koga, D.; Harashima, S.; Gao, X.; Tezuka, Y.; Omata, K.; Ono, Y.; Morimoto, R.; Satoh, F.; et al. The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA). Int. J. Mol. Sci. 2022, 23, 2174. https://doi.org/10.3390/ijms23042174
AMA Style
Motomura N, Yamazaki Y, Koga D, Harashima S, Gao X, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, et al. The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA). International Journal of Molecular Sciences. 2022; 23(4):2174. https://doi.org/10.3390/ijms23042174
Chicago/Turabian StyleMotomura, Naoki, Yuto Yamazaki, Daiki Koga, Shogo Harashima, Xin Gao, Yuta Tezuka, Kei Omata, Yoshikiyo Ono, Ryo Morimoto, Fumitoshi Satoh, and et al. 2022. "The Association of Cholesterol Uptake and Synthesis with Histology and Genotype in Cortisol-Producing Adenoma (CPA)" International Journal of Molecular Sciences 23, no. 4: 2174. https://doi.org/10.3390/ijms23042174
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
